Comparison of blood sirolimus, tacrolimus and everolimus concentrations measured by LC-MS/MS, HPLC-UV and immunoassay methods
Comparison of blood sirolimus, tacrolimus and everolimus concentrations measured by LC-MS/MS, HPLC-UV and immunoassay methods
复制标题
DOI:
10.1016/j.clinbiochem.2010.10.005
复制
发表时间:
2011-02-01
影响因子:
2.8
通讯作者:
Morris, Raymond G.
中科院分区:
文献类型:
--
作者:
Sallustio, Benedetta C.;Noll, Benjamin D.;Morris, Raymond G.
Objectives: An LC-MS/MS method was developed for simultaneous quantitation of tacrolimus, sirolimus and everolimus in whole blood, and compared to HPLC-UV and immunoassay methods.Design and methods: Blood (0.1 mL) was analysed following solid-phase extraction and chromatographic resolution using a C18 column (45 degrees C) and mobile phase of methanol/40 mM ammonium acetate/glacial acetic acid (83/17/0.1) at 200 mu L/inin, with positive electrospray ionisation and multiple reaction monitoring.Results: Intra- and inter-day imprecision and inaccuracy were 30% bias in FPIA everolimus concentrations measured in pooled patient samples versus spiked drug-free whole blood.Conclusions: LC-MS/MS provides significant accuracy and precision advantages compared to HPLC and immunoassays. Discrepancies in everolimus concentrations measured by the Seradyn FPIA immunoassay require further investigation. (C) 2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.